Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Immunocore Holdings plc ADR shares valued at $1,261,789 were sold by Berman David M on Dec 04 ’25. At $40.26 per share, Berman David M sold 31,341 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, Berman David M sold 572 shares, netting a total of over 22,960 in proceeds. Following the sale of shares at $40.14 each, the insider now holds 0 shares.
Before that, Berman David M had sold 69,404 shares from its account. In a trade valued at $2,784,488, the HEAD OF R&D traded Immunocore Holdings plc ADR shares for $40.12 each. Upon closing the transaction, the insider’s holdings decreased to 69,404 shares, worth approximately $0.0.
As published in their initiating research note from Wells Fargo on October 31, 2025, Immunocore Holdings plc ADR [IMCR] has been an Overweight and the price target has been revised to $60. Earlier on May 27, 2025, Deutsche Bank initiated its rating. Their recommendation was “a Buy” for IMCR stock.
Analyzing IMCR Stock Performance
On last trading session, Immunocore Holdings plc ADR [NASDAQ: IMCR] rose 1.05% to $36.57. The stock’s lowest price that day was $35.51, but it reached a high of $37.25 in the same session. During the last five days, there has been a surge of approximately 2.09%. Over the course of the year, Immunocore Holdings plc ADR shares have jumped approximately 29.11%. Shares of the company reached a 52-week high of $40.71 on 12/05/25 and a 52-week low of $23.15 on 04/09/25.
Support And Resistance Levels for Immunocore Holdings plc ADR (IMCR)
According to the 24-hour chart, there is a support level at 35.64, which, if violated, would cause prices to drop to 34.70. In the upper region, resistance lies at 37.38. The next price resistance is at 38.18. RSI (Relative Strength Index) is 50.42 on the 14-day chart, showing neutral technical sentiment.
Is Immunocore Holdings plc ADR subject to short interest?
Stocks of Immunocore Holdings plc ADR saw a sharp steep in short interest on 2025-11-28 dropping by 90328.0 shares to 8.56 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 8.66 million shares. A decline of -1.05% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 28.13 of the overall float, the days-to-cover ratio (short ratio) decline to 28.13.
Which companies own the most shares of Immunocore Holdings plc ADR (IMCR)?
In terms of Immunocore Holdings plc ADR share price expectations, FactSet research, analysts set an average price target of 48 in the next 12 months, up nearly 32.63% from the previous closing price of $36.19. Analysts anticipate Immunocore Holdings plc ADR stock to reach 60 by 2025, with the lowest price target being 36. In spite of this, 7 analysts ranked Immunocore Holdings plc ADR stock as Buy at the end of 2025. On December 13, 2024, Morgan Stanley assigned a price target of “an Equal-weight” to the stock and downgraded coverage with a $35.
